Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apolipoprotein B mRNA editing enzyme catalytic subunit 3A pseudogene 1 (APOBEC3AP1) is a processed pseudogene related to the APOBEC3A gene, which belongs to the cytidine deaminase gene family involved in anti-viral immunity and DNA editing*[5][6]*. As a pseudogene, APOBEC3AP1 does not encode a functional protein but may participate in regulation at the RNA level, such as via antisense transcripts, small interfering RNAs, or serving as a competitive endogenous RNA that can modulate gene expression in the genome*[2]*. Like many pseudogenes, APOBEC3AP1 may exert subtle regulatory effects on its parental gene or related pathways and can potentially act as a biomarker for specific disease conditions, although there is currently no direct evidence that it plays a significant disease or therapeutic target role on its own*[2][6]*. Pseudogenes such as APOBEC3AP1 can sometimes influence disease by affecting the expression, splicing, or regulation of related protein-coding genes, especially in cancer and other complex diseases, but are not typical therapeutic targets*[2]*. APOBEC3A (the parental gene) participates in immunity, DNA editing, and has been linked to specific diseases (e.g., cancer), but APOBEC3AP1 itself is not known to have direct pathogenic or therapeutic relevance*[1][5]*.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apolipoprotein B mRNA editing enzyme catalytic subunit 3A pseudogene 1 (APOBEC3AP1).